Ataxia Telangiectasia Mutated protein kinase (ATM) has lately come to the fore as a regulatory protein fulfilling many roles within the fantastic balancing act of metabolic homeostasis. Greatest recognized for its position as a transducer of DNA harm restore, the exercise of ATM within the cytosol is having fun with growing consideration, the place it performs a central position typically mobile recycling (macroautophagy) in addition to the focused clearance (selective autophagy) of broken mitochondria and peroxisomes in response to oxidative stress, independently of the DNA harm response.
The significance of ATM activation by oxidative stress has additionally lately been highlighted within the clearance of protein aggregates, the place the expression of a practical ATM assemble that can’t be activated by oxidative stress resulted in widespread accumulation of protein aggregates. This assessment will focus on the position of ATM typically autophagy, mitophagy, and pexophagy in addition to aggrephagy and crosstalk between oxidative stress as an activator of ATM and its potential position as a grasp regulator of those processes.
Mycobacterium tuberculosis Thymidylyltransferase RmlA Is Negatively Regulated by Ser/Thr Protein Kinase PknB
Ser/Thr phosphorylation by serine/threonine protein kinases (STPKs) performs vital roles in molecular regulation, which permits Mycobacteria to adapt their cell wall construction in response to the atmosphere adjustments. Figuring out direct targets of STPKs and figuring out their actions are subsequently important to revealing their perform in Mycobacteria, for instance, in cell wall formation and virulence. Herein, we reported that RmlA, a vital L-rhamnose biosynthesis enzyme, is a substrate of STPK PknB in Mycobacterium tuberculosis (M. tuberculosis).
Mass spectrometry evaluation revealed that RmlA is phosphorylated at Thr-12, Thr-54, Thr-197, and Thr-12 is situated near the catalytic triad of RmlA. Biochemical and phenotypic evaluation of two RmlA mutants, T12A/T12D, confirmed that their actions have been decreased, and cell wall formation was negatively affected. Furthermore, virulence of RmlA T12D mutant was attenuated in a macrophage mannequin. Total, these outcomes present the primary proof for the position of PknB-dependent RmlA phosphorylation in regulating cell wall formation in Mycobacteria, with vital implications for pathogenicity.
BRASSINOSTEROID-SIGNALING KINASE 1 phosphorylating CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE capabilities in drought tolerance in maize
Drought stress critically limits crop productiveness. Though research have been carried out, it’s nonetheless largely unknown that how plant responds to drought stress. Right here we discover that drought remedy can improve the phosphorylation exercise of brassinosteroid-signaling kinase 1 (ZmBSK1) in maize (Zea mays). Our genetic research reveal that ZmBSK1 positively impacts drought tolerance in maize crops. ZmBSK1 localizes in plasma membrane, interacts with calcium/calmodulin-dependent protein kinase (ZmCCaMK), and phosphorylates ZmCCaMK. Ser-67 is an important phosphorylation website of ZmCCaMK by ZmBSK1.
Drought stress enhances not solely the interplay between ZmBSK1 and ZmCCaMK but additionally the phosphorylation of Ser-67 in ZmCCaMK by ZmBSK1. Moreover, Ser-67 phosphorylation in ZmCCaMK regulates its Ca2+ /CaM binding, autophosphorylation exercise and transphosphorylation exercise, and positively impacts its perform in drought tolerance in maize. Our outcomes reveal an essential position of ZmBSK1 in drought tolerance and recommend a direct regulatory mode of ZmBSK1 phosphorylating ZmCCaMK.
Methamphetamine publicity induces neuronal programmed necrosis by activating the receptor-interacting protein kinase 3 -related signalling pathway
Methamphetamine (METH) is an artificial drug with extreme neurotoxicity, nevertheless, the regulation of METH-induced neuronal programmed necrosis stays poorly understood. The goal of this research was to determine the molecular mechanisms of METH-induced neuronal programmed necrosis. We discovered that neuronal programmed necrosis occurred within the striatum of mind samples from human and mice that have been uncovered to METH.
The receptor-interacting protein kinase 3 (RIP3) was extremely expressed within the neurons of human and mice uncovered to METH, and RIP3-silenced or RIP1-inhibited protected neurons developed neuronal programmed necrosis in vitro and in vivo following METH publicity. Furthermore, the RIP1-RIP3 complicated causes cell programmed necrosis by regulating blended lineage kinase domain-like protein (MLKL)-mediated cell membrane rupture and dynamin-related protein 1 (Drp1)-mediated mitochondrial fission. Collectively, these information point out that RIP3 performs an indispensable position within the mechanism of METH-induced neuronal programmed necrosis, which can characterize a possible therapeutic goal for METH-induced neurotoxicity.
Pyruvate kinase M2 in persistent inflammations: a potpourri of essential protein–protein interactions
Power irritation (CI) is a major contributing issue concerned in a number of ailments like most cancers, stroke, diabetes, Alzheimer’s illness, allergy, bronchial asthma, autoimmune ailments, coeliac illness, glomerulonephritis, sepsis, hepatitis, inflammatory bowel illness, reperfusion harm, and transplant rejections. Regardless of a number of expansions in our understanding of inflammatory issues and their mediators, it appears clear that quite a few proteins take part within the onset of CI. One essential protein pyruvate kinase M2 (PKM2) a lot studied in most cancers can be discovered to be inextricably woven within the onset of a number of CI’s. It has been discovered that PKM2 performs a big position in a number of issues utilizing a community of proteins that work together in a number of methods.
As an illustration, PKM2 types an in depth affiliation with epidermal development issue receptors (EGFRs) for uncontrolled development and proliferation of tumor cells. In neurodegeneration, PKM2 interacts with apurinic/apyrimidinic endodeoxyribonuclease 1 (APE1) to onset Alzheimer’s illness pathogenesis. The cross-talk of protein tyrosine phosphatase 1B (PTP1B) and PKM2 acts as stepping stones for the graduation of diabetes. Maybe PKM2 shops the potential to unlock the pathophysiology of a number of ailments.
 anti-NQO1 |
|
YF-PA11356 |
Abfrontier |
100 ug |
EUR 483.6 |
|
Description: Rabbit polyclonal to NQO1 |
 ELISA Kit) Mouse NADH Dehydrogenase, Quinone 1 (NQO1) ELISA Kit |
|
DLR-NQO1-Mu-48T |
DL Develop |
48T |
EUR 679.2 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse NADH Dehydrogenase, Quinone 1 (NQO1) in samples from tissue homogenates, cell lysates or other biological fluids. |
Mouse NADH Dehydrogenase, Quinone 1 (NQO1) ELISA Kit |
|
DLR-NQO1-Mu-96T |
DL Develop |
96T |
EUR 889.2 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse NADH Dehydrogenase, Quinone 1 (NQO1) in samples from tissue homogenates, cell lysates or other biological fluids. |
 ELISA Kit) Rat NADH Dehydrogenase, Quinone 1 (NQO1) ELISA Kit |
|
DLR-NQO1-Ra-48T |
DL Develop |
48T |
EUR 708 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat NADH Dehydrogenase, Quinone 1 (NQO1) in samples from tissue homogenates, cell lysates or other biological fluids. |
Rat NADH Dehydrogenase, Quinone 1 (NQO1) ELISA Kit |
|
DLR-NQO1-Ra-96T |
DL Develop |
96T |
EUR 928.8 |
|
|
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat NADH Dehydrogenase, Quinone 1 (NQO1) in samples from tissue homogenates, cell lysates or other biological fluids. |
Mouse NADH Dehydrogenase, Quinone 1 (NQO1) ELISA Kit |
|
RD-NQO1-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 692.4 |
Mouse NADH Dehydrogenase, Quinone 1 (NQO1) ELISA Kit |
|
RD-NQO1-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 962.4 |
Rat NADH Dehydrogenase, Quinone 1 (NQO1) ELISA Kit |
|
RD-NQO1-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 723.6 |
Rat NADH Dehydrogenase, Quinone 1 (NQO1) ELISA Kit |
|
RD-NQO1-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 1008 |
Mouse NADH Dehydrogenase, Quinone 1 (NQO1) ELISA Kit |
|
RDR-NQO1-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 723.6 |
Mouse NADH Dehydrogenase, Quinone 1 (NQO1) ELISA Kit |
|
RDR-NQO1-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 1008 |
Rat NADH Dehydrogenase, Quinone 1 (NQO1) ELISA Kit |
|
RDR-NQO1-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 757.2 |
Rat NADH Dehydrogenase, Quinone 1 (NQO1) ELISA Kit |
|
RDR-NQO1-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 1056 |
 anti- NQO1 antibody |
|
FNab05830 |
FN Test |
100µg |
EUR 606.3 |
|
|
|
Description: Antibody raised against NQO1 |
) anti-NQO1 (4D12) |
|
LF-MA30655 |
Abfrontier |
100 ul |
EUR 632.4 |
|
Description: Mouse Monoclonal to NQO1 |
) anti-NQO1 (1A11) |
|
LF-MA30656 |
Abfrontier |
100 ul |
EUR 632.4 |
|
Description: Mouse Monoclonal to NQO1 |
 Anti-NQO1 Antibody |
|
PB9497 |
BosterBio |
100ug/vial |
EUR 352.8 |
 Anti-NQO1 antibody |
|
STJ24804 |
St John's Laboratory |
100 µl |
EUR 332.4 |
|
Description: This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized. |
Anti-NQO1 antibody |
|
STJ24805 |
St John's Laboratory |
100 µl |
EUR 332.4 |
|
Description: This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized. |
Anti-NQO1 antibody |
|
STJ94551 |
St John's Laboratory |
200 µl |
EUR 236.4 |
|
Description: Rabbit polyclonal to NQO1. |
 Rabbit Polyclonal antibody Anti-CRBN |
|
Anti-CRBN |
ImmunoStep |
50 µg |
EUR 418.8 |
) NQO1 Recombinant Protein (Human) |
|
RP078738 |
ABM |
100 ug |
Ask for price |
) Anti-NQO1 (1E3-A6) |
|
YF-MA12677 |
Abfrontier |
100 ug |
EUR 435.6 |
|
Description: Mouse monoclonal to NQO1 |
 NQO1, human recombinant |
|
7571-10 |
Biovision |
|
EUR 392.4 |
NQO1, human recombinant |
|
7571-50 |
Biovision |
|
EUR 1123.2 |
 Human NQO1 Antibody |
|
32959-05111 |
AssayPro |
150 ug |
EUR 313.2 |
 Polyclonal Goat Anti-NQO1 Antibody |
|
AMM05061G |
Leading Biology |
0.1 mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-NQO1 . This antibody is tested and proven to work in the following applications: |
) Anti-NQO1 Monoclonal Antibody (A180) |
|
M00494-1 |
BosterBio |
200ug |
EUR 597.6 |
|
Description: Mouse Monoclonal NQO1 Antibody (A180). Validated in WB and tested in Human. |
 NQO1 Antibody |
|
1-CSB-PA102829 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against NQO1. Recognizes NQO1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
NQO1 Antibody |
|
1-CSB-PA003475 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against NQO1. Recognizes NQO1 from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000 |
 NQO1 siRNA |
|
20-abx926309 |
Abbexa |
|
|
|
|
NQO1 siRNA |
|
20-abx926310 |
Abbexa |
|
|
|
|
NQO1 Antibody |
|
1-CSB-PA016039GA01HU |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against NQO1. Recognizes NQO1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
NQO1 Antibody |
|
1-CSB-PA016039LA01HU |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against NQO1. Recognizes NQO1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
NQO1 Antibody |
|
1-CSB-PA890070 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against NQO1. Recognizes NQO1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:10000, WB:1:500-1:2000, IHC:1:50-1:200 |
 NQO1 antibody |
|
70R-49661 |
Fitzgerald |
100 ul |
EUR 292.8 |
|
Description: Purified Polyclonal NQO1 antibody |
NQO1 Antibody |
|
32295-100ul |
SAB |
100ul |
EUR 302.4 |
 NQO1 Peptide |
|
45-981P |
ProSci |
0.1 mg |
EUR 405.6 |
|
Description: NQO1 Peptide |
NQO1 Antibody |
|
49364-100ul |
SAB |
100ul |
EUR 399.6 |
NQO1 Antibody |
|
49364-50ul |
SAB |
50ul |
EUR 286.8 |
NQO1 antibody |
|
70R-10256 |
Fitzgerald |
50 ug |
EUR 560.4 |
|
Description: Affinity purified rabbit polyclonal NQO1 antibody |
NQO1 antibody |
|
70R-10257 |
Fitzgerald |
50 ug |
EUR 560.4 |
|
Description: Affinity purified rabbit polyclonal NQO1 antibody |
NQO1 antibody |
|
70R-12504 |
Fitzgerald |
100 ul |
EUR 548.4 |
|
Description: Affinity purified Rabbit polyclonal NQO1 antibody |
NQO1 antibody |
|
70R-18946 |
Fitzgerald |
50 ul |
EUR 522 |
|
Description: Rabbit polyclonal NQO1 antibody |
NQO1 Peptide |
|
42-451P |
ProSci |
0.1 mg |
EUR 405.6 |
|
Description: (IN) NQO1 Peptide |
NQO1 antibody |
|
22937-100ul |
SAB |
100ul |
EUR 468 |
NQO1 Antibody |
|
35365-100ul |
SAB |
100ul |
EUR 468 |
NQO1 Antibody |
|
31283-100ul |
SAB |
100ul |
EUR 302.4 |
NQO1 Antibody |
|
31283-50ul |
SAB |
50ul |
EUR 224.4 |
NQO1 siRNA |
|
20-abx903636 |
Abbexa |
|
|
|
|
 h NQO1 |
|
LVP1058 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 541.2 |
|
Description: Pre-made over-expression lentivirus for expressing human target: NQO1 (NAD(P)H quinone dehydrogenase 1), [alternative names: DHQU; DIA4; DTD; NMOR1; NMORI; QR1]. The sub-cloned codon sequence is identical (100% match) to CDS region in NCBI ID: NM_000903. It also contains a RFP-Blasticidin dual selection marker. |
) NQO1 protein (His tag) |
|
80R-1197 |
Fitzgerald |
100 ug |
EUR 703.2 |
|
Description: Purified recombinant Human NQO1 protein |
) NQO1 Recombinant Protein (Rat) |
|
RP214418 |
ABM |
100 ug |
Ask for price |
) NQO1 Recombinant Protein (Mouse) |
|
RP154820 |
ABM |
100 ug |
Ask for price |
 Human NQO1 shRNA Plasmid |
|
20-abx951197 |
Abbexa |
|
|
|
|
 Polyclonal Goat anti-GST α-form |
|
GST-ANTI-1 |
Detroit R&D |
50 uL |
EUR 336 |
 Polyclonal Goat anti-GST μ-form |
|
GST-ANTI-2 |
Detroit R&D |
50 uL |
EUR 336 |
 Polyclonal Goat anti-GST p-form |
|
GST-ANTI-3 |
Detroit R&D |
50 uL |
EUR 336 |
 NQO1 Blocking Peptide |
|
DF6437-BP |
Affbiotech |
1mg |
EUR 234 |
 NQO1 Conjugated Antibody |
|
C31283 |
SAB |
100ul |
EUR 476.4 |
NQO1 Conjugated Antibody |
|
C32295 |
SAB |
100ul |
EUR 476.4 |
NQO1 Conjugated Antibody |
|
C49364 |
SAB |
100ul |
EUR 476.4 |
 NQO1 Polyclonal Antibody |
|
ES2983-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against NQO1 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
NQO1 Polyclonal Antibody |
|
ES2983-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against NQO1 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
 NQO1 ELISA Kit |
|
55R-1433 |
Fitzgerald |
100 assays |
EUR 1743.6 |
|
Description: ELISA kit for detection of NQO1 in the research laboratory |
 NQO1 Rabbit pAb |
|
A1518-100ul |
Abclonal |
100 ul |
EUR 369.6 |
NQO1 Rabbit pAb |
|
A1518-200ul |
Abclonal |
200 ul |
EUR 550.8 |
NQO1 Rabbit pAb |
|
A1518-20ul |
Abclonal |
20 ul |
EUR 219.6 |
NQO1 Rabbit pAb |
|
A1518-50ul |
Abclonal |
50 ul |
EUR 267.6 |
NQO1 Polyclonal Antibody |
|
41254-100ul |
SAB |
100ul |
EUR 302.4 |
NQO1 Polyclonal Antibody |
|
41254-50ul |
SAB |
50ul |
EUR 224.4 |
NQO1 Blocking Peptide |
|
33R-1274 |
Fitzgerald |
100 ug |
EUR 216 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GOT2 antibody, catalog no. 70R-1560 |
NQO1 Blocking Peptide |
|
3639BP-50 |
Biovision |
|
EUR 183.6 |
NQO1 Blocking Peptide |
|
33R-9961 |
Fitzgerald |
100 ug |
EUR 216 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NQO1 antibody, catalog no. 70R-10256 |
NQO1 Polyclonal Antibody |
|
ABP51984-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
|
|
Description: A polyclonal antibody for detection of NQO1 from Human. This NQO1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human NQO1 |
NQO1 Polyclonal Antibody |
|
ABP51984-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
|
|
Description: A polyclonal antibody for detection of NQO1 from Human. This NQO1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human NQO1 |
NQO1 Polyclonal Antibody |
|
ABP51984-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
|
|
Description: A polyclonal antibody for detection of NQO1 from Human. This NQO1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human NQO1 |
NQO1 Blocking Peptide |
|
20-abx062536 |
Abbexa |
|
|
|
|
 NQO1 Rabbit mAb |
|
A19586 |
Abclonal |
20 μL |
EUR 18 |
NQO1 Rabbit mAb |
|
A19586-100ul |
Abclonal |
100 ul |
EUR 492 |
NQO1 Rabbit mAb |
|
A19586-200ul |
Abclonal |
200 ul |
EUR 685.2 |
NQO1 Rabbit mAb |
|
A19586-20ul |
Abclonal |
20 ul |
EUR 265.2 |
NQO1 Rabbit mAb |
|
A19586-50ul |
Abclonal |
50 ul |
EUR 344.4 |
NQO1 Rabbit pAb |
|
A0047-100ul |
Abclonal |
100 ul |
EUR 369.6 |
NQO1 Rabbit pAb |
|
A0047-200ul |
Abclonal |
200 ul |
EUR 550.8 |
NQO1 Rabbit pAb |
|
A0047-20ul |
Abclonal |
20 ul |
EUR 219.6 |
NQO1 Rabbit pAb |
|
A0047-50ul |
Abclonal |
50 ul |
EUR 267.6 |
 Polyclonal NQO1 Antibody |
|
APR08804G |
Leading Biology |
0.1mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human NQO1 . This antibody is tested and proven to work in the following applications: |
) Human NQO1 Antibody (Biotin Conjugate) |
|
32959-05121 |
AssayPro |
150 ug |
EUR 442.8 |
 Human Intracellular NQO1 ELISA Kit |
|
LF-EK70031 |
Abfrontier |
1×96T |
EUR 722.4 |
 (OKCD09345)) NQO1 ELISA Kit (Human) (OKCD09345) |
|
OKCD09345 |
Aviva Systems Biology |
96 Wells |
EUR 1090.8 |
|
Description: Description of target: This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.122ng/mL |
 (pORF)) NQO1 ORF Vector (Human) (pORF) |
|
ORF026247 |
ABM |
1.0 ug DNA |
EUR 114 |
 ELISA Kit) NQO1 (human intracellular) ELISA Kit |
|
K4926-100 |
Biovision |
|
EUR 1149.6 |
 Protein) Human NADH Dehydrogenase, Quinone 1 (NQO1) Protein |
|
20-abx167110 |
Abbexa |
-
EUR 844.80
-
EUR 343.20
-
EUR 2598.00
-
EUR 994.80
-
EUR 594.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 (pPB-C-His)) NQO1 Protein Vector (Human) (pPB-C-His) |
|
PV104986 |
ABM |
500 ng |
EUR 394.8 |
 (pPB-N-His)) NQO1 Protein Vector (Human) (pPB-N-His) |
|
PV104987 |
ABM |
500 ng |
EUR 394.8 |
Right here we offer an summary of the notoriously convoluted biology of CI’s and PKM2. The cross-talk of PKM2 with a number of proteins concerned in stroke, Alzheimer’s, most cancers, and different ailments has additionally been mentioned. We consider that contemplating the significance of PKM2 in inflammation-related ailments, new choices for treating numerous issues with the event of extra selective brokers concentrating on PKM2 could seem.
